Observational Study of Correlation Between Recurrent Basal Cell Carcinoma and Localisation
Observational Study of Basal Cell Carcinoma Operated at Montpellier University Hospital and Millau Hospital From February 2020 to February 2021 - Study of Correlation Between Localisation and Recurrence, and Other Criterias
1 other identifier
observational
804
1 country
1
Brief Summary
.During one year all the resected basal cell carcinomas (BCC) analyzed in Montpellier University Hospital Anatomopathology unit were included in this study. Localisation and histological characteristics were collected. All the recurrences of BCC were searched from the medical records (or histopathology request form). From 804 BCC, 48 were recurrent BCC with or without complete first resection. Patients with recurrent BCC were contacted to obtain agreement and more informations about the first resection and some clinical informations like sun exposure and phototype. The statistical analysis focused on the localisation of recurrent BCC (with a complete first resection) compared to localisations of primary BCC in this population. The goal was to identified localisations with an increased risk of recurrences.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 20, 2021
CompletedFirst Submitted
Initial submission to the registry
March 10, 2021
CompletedFirst Posted
Study publicly available on registry
March 12, 2021
CompletedMarch 12, 2021
March 1, 2021
1 year
March 10, 2021
March 10, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
- Determined For each localisation the number of primary and recurrent BCC and analysis of localisation with higher risk of BCC
\- Determined For each localisation the number of primary and recurrent BCC and analysis of localisation with higher risk of BCC
1 day
Secondary Outcomes (3)
Analysis of correlation between localisation and histology characteristics
1 day
Analysis of correlation between histological type and recurrence risk
1 day
Analysis if there is a difference between first resection histological type and the recurrent histological type
1 day
Study Arms (2)
recurrent BCC
recurrent BCC
resected BCC
resected BCC
Eligibility Criteria
Cohort : All the resected BCC during one year in Montpellier University Hospital and Millau Hospital (both analyzed in anatomopathology unit in Montpellier University Hospital). Cases : All the cases of recurrent BCC, found after research in medical records or histopathology request form.
You may qualify if:
- \- Patients with resected BCC
You may not qualify if:
- Biopsies of BCC,
- revised surgery of incomplete resection.
- Cases :
- Recurrent BCC with complete first resection
- \- Recurrent BCC with incomplete first resection, Patients with Gorlin syndrome (a genetic disease that increase risk of BCC)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Uhmontpellier
Montpellier, 34295, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sophie Pons, Resident
University Hospital, Montpellier
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 10, 2021
First Posted
March 12, 2021
Study Start
February 1, 2020
Primary Completion
February 1, 2021
Study Completion
February 20, 2021
Last Updated
March 12, 2021
Record last verified: 2021-03